Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;48(12):e255-e262.
doi: 10.1097/OLQ.0000000000001407.

Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review

Luyan Zheng  1 , Jie Wu, Min Zheng
Affiliations

Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review

Luyan Zheng et al. Sex Transm Dis. .

Abstract

Background: Cervical and oropharyngeal cancers are associated with human papillomavirus (HPV) infection, which can be prevented with the vaccines. However, uptake of the HPV vaccine remains low in many countries. There is a need to better understand the barriers to and facilitators of HPV vaccination from young people's perspectives.

Methods: Five electronic databases were searched for original publications (dated January, 2006-December, 2019) reporting barriers to and facilitators of HPV vaccination among young people. All articles were screened against prespecified eligibility criteria, and data were extracted against prespecified form.

Results: A total of 13 studies that were published in international peer-reviewed journals and met the stated eligibility criteria were identified. The barriers reported were centralized around lack of knowledge about HPV and the HPV vaccine, fear about the safety and efficacy of the HPV vaccine, fear about not being able to pay for the HPV vaccine, and discrimination regarding to the HPV vaccine. The facilitators reported were centralized around trust in the efficacy and safety of the HPV vaccine, discounted price of vaccination, positive recommendations from others, perceived risk of HPV infection, and benefits of vaccine.

Conclusions: After their introduction 14 years ago, knowledge deficiency of the HPV vaccine is still a critical barrier to vaccination. Educational initiatives aimed at adolescents and young adults were urgently needed. Understanding factors that arbitrate in early HPV vaccination is critical for improving the HPV vaccination rate.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest and Sources of Funding: The authors declare that they have no known competing financial interests or personal relationships that could have seemed to influence the work reported in this article. The authors report no funding sources.

Figures

Figure 1
Figure 1
Flowchart for the identification and inclusion of articles in the systematic review.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40:80–85. - PubMed
    1. Viens LJ Henley SJ Watson M, et al. . Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65:661–666. - PubMed
    1. de Martel C Plummer M Vignat J, et al. . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141:664–670. - PMC - PubMed
    1. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006; 110:525–541. - PubMed
    1. Chaturvedi AK Anderson WF Lortet-Tieulent J, et al. . Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31:4550–4559. - PMC - PubMed

Publication types

Substances